Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | fms-related tyrosine kinase 3 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | monoglyceride lipase, putative | 0.0074 | 0.6425 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0074 | 0.6425 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0074 | 0.6425 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0105 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0074 | 0.6425 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0105 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0074 | 0.6425 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0105 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0074 | 0.6425 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0074 | 0.6425 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0105 | 1 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.0074 | 0.6425 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0074 | 0.6425 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0105 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0074 | 0.6425 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0074 | 0.6425 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0074 | 0.6425 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0074 | 0.6425 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0074 | 0.6425 | 0.5 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.002 | 0.0198 | 0.0198 |
Schistosoma mansoni | amidase | 0.0105 | 1 | 1 |
Plasmodium falciparum | esterase, putative | 0.0074 | 0.6425 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0074 | 0.6425 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.002 | 0.0198 | 0.0198 |
Loa Loa (eye worm) | hypothetical protein | 0.0105 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0074 | 0.6425 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.025 uM | Antiproliferative activity against human BaF3 cells expressing FLT3 | ChEMBL. | 17611106 |
IC50 (functional) | = 0.025 uM | Antiproliferative activity against human BaF3 cells expressing FLT3 | ChEMBL. | 17611106 |
IC50 (binding) | = 0.15 uM | Inhibition of human FLT3 | ChEMBL. | 17611106 |
IC50 (binding) | = 0.15 uM | Inhibition of human FLT3 | ChEMBL. | 17611106 |
IC50 (functional) | = 0.554 uM | Antiproliferative activity against human MV411 cells | ChEMBL. | 17611106 |
IC50 (functional) | = 0.554 uM | Antiproliferative activity against human MV411 cells | ChEMBL. | 17611106 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 17611106 | |
Homo sapiens | ChEMBL23 | 17611106 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.